Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alexander Egeberg is a Danish professional entity and consultancy founded by Professor Alexander Egeberg, a globally recognized leader in dermatology and clinical epidemiology. The company provides specialized medical advisory, clinical trial design, and strategic consulting services to the pharmaceutical and biotechnology industries. Its core focus lies in the research and development of treatments for inflammatory skin diseases, such as psoriasis, atopic dermatitis, and hidradenitis suppurativa. The entity leverages Professor Egeberg's extensive experience as a Chief Physician and Professor at the University of Copenhagen to bridge the gap between academic research and commercial drug development. It has collaborated with numerous top-tier pharmaceutical companies to advance the clinical understanding of biologics and small molecule inhibitors. The company is instrumental in providing real-world evidence and epidemiological insights that inform market access and therapeutic positioning.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alexander Egeberg.